An oral chitosan DNA vaccine against nodavirus improves transcription of cell-mediated cytotoxicity and interferon genes in the European sea bass juveniles gut and survival upon infection
MetadataShow full item record
AuthorsValero, Y. (Yulema); Award, E. (Elham); Buonocore, F. (Francesco); Arizcun-Arizcun, M. (Marta); Esteban, M.A. (Maria Ángeles); Meseguer, J. (Jóse); Chaves-Pozo, E. (Elena); Cuesta, A. (Alberto)
Vaccines for fish need to be improved for the aquaculture sector, with DNA vaccines and the oral administration route providing the most promising improvements. In this study, we have created an oral chitosan-encapsulated DNA vaccine (CP-pNNV) for the nodavirus (NNV) in order to protect the very susceptible European sea bass (Dicentrarchus labrax). Our data show that the oral CP-pNNV vaccine failed to induce serum circulating or neutralizing specific antibodies (immunoglobulin M) or to up-regulate their gene expression in the posterior gut. However, the vaccine up-regulated the expression of genes related to the cell-mediated cytotoxicity (CMC; tcrb and cd8a) and the interferon pathway (IFN; ifn, mx and ifng). In addition, 3 months after vaccination, challenged fish showed a retarded onset of fish death and lower cumulative mortality with a relative survival of 45%. Thus,we created a chitosan-encapsulated DNA vaccine against NNV that is partly protective to European sea bass juveniles ...
The following license files are associated with this item: